Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01584635 · ClinicalTrials.gov registry record · NA
The Role That Peroral Endoscopic Myotomy (POEM) Could Play in the Treatment of Achalasia
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01584635: Completed NA study, sponsored by Mayo Clinic.
NCT01584635 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01584635, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Based on the work of the Doctors at the Mayo Clinic Rochester, a new technique for a less invasive treatment for Achalasia has been developed. The purpose of this study is to decide the role this less invasive treatment (Peroral Endoscopic Myotomy) has in the treatment of patient's with achalasia.
Interventions
- PROCEDURE Peroral Endoscopic Myotomy a less invasive treatment for Achalasia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01584635
The ClinicalTrials.gov registry entry for NCT01584635 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peroral Endoscopic Myotomy a less invasive treatment for Achalasia is the first listed.
NCT01584635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01584635 about?
NCT01584635 is a clinical study titled "The Role That Peroral Endoscopic Myotomy (POEM) Could Play in the Treatment of Achalasia". Based on the work of the Doctors at the Mayo Clinic Rochester, a new technique for a less invasive treatment for Achalasia has been developed. The purpose of this study is to decide the role this less invasive treatment (Peroral Endoscopic Myotomy) has in the treatment of patient's with achalasia.
What is the current status of trial NCT01584635?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-01. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01584635?
The interventions under investigation include: Peroral Endoscopic Myotomy a less invasive treatment for Achalasia (PROCEDURE).
Who is sponsoring clinical trial NCT01584635?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.